Posts by Paula

Birmingham University and Nonacus partner to develop urine test for bladder cancer

Last July we announced that Nonacus and the University of Birmingham had partnered to develop a non-invasive test for bladder cancer. The test uses highly sensitive liquid biopsy technology developed by Nonacus, and a panel of biomarkers validated by Dr Rik Bryan and Dr Douglas Ward from the University’s Bladder Cancer Research Centre, to diagnose the disease from urine samples. Now, less that a year later, the first results are in.
Read More

Non-invasive fetal Rhesus D blood genotyping

Non-invasive prenatal testing (NIPT) using cell-free fetal DNA in maternal plasma is being used to determine fetal RhD blood group antigen status so that RhD-negative pregnant women can avoid receiving antenatal anti-D if they are carrying a RhD-negative baby.
Read More

Introducing Whole Genome Sequencing service

Government regulations, recently announced in the UK, now require Whole Genome Sequencing to be carried out as part of the minimum standards for COVID-19 tests for people arriving in England. In order to support SARS-CoV-2 testing laboratories, we have introduced a Whole Genome Sequencing service.
Read More